Ignite Creation Date:
2024-05-06 @ 5:19 PM
Last Modification Date:
2024-10-26 @ 2:26 PM
Study NCT ID:
NCT05267327
Status:
NOT_YET_RECRUITING
Last Update Posted:
2022-03-04
First Post:
2022-02-28
Brief Title:
A Prospective Post-Marketing Observational Safety Study of Verzenios Abemaciclib Among Breast Cancer Patients in China Verzenios Abemaciclib Among Breast
Sponsor:
Organization:
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University